BeiGene Other Operating Expenses vs Interest Income Analysis
BGNE Stock | USD 156.17 11.75 7.00% |
BeiGene financial indicator trend analysis is way more than just evaluating BeiGene prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether BeiGene is a good investment. Please check the relationship between BeiGene Other Operating Expenses and its Interest Income accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.
Other Operating Expenses vs Interest Income
Other Operating Expenses vs Interest Income Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of BeiGene Other Operating Expenses account and Interest Income. At this time, the significance of the direction appears to have pay attention.
The correlation between BeiGene's Other Operating Expenses and Interest Income is -0.93. Overlapping area represents the amount of variation of Other Operating Expenses that can explain the historical movement of Interest Income in the same time period over historical financial statements of BeiGene, assuming nothing else is changed. The correlation between historical values of BeiGene's Other Operating Expenses and Interest Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Operating Expenses of BeiGene are associated (or correlated) with its Interest Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Interest Income has no effect on the direction of Other Operating Expenses i.e., BeiGene's Other Operating Expenses and Interest Income go up and down completely randomly.
Correlation Coefficient | -0.93 |
Relationship Direction | Negative |
Relationship Strength | Significant |
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of BeiGene. It is also known as BeiGene overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Interest Income
Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.Most indicators from BeiGene's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into BeiGene current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.At present, BeiGene's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 17.4 B, whereas Sales General And Administrative To Revenue is forecasted to decline to 0.84.
2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 990.9M | 1.3B | 3.2B | 3.4B | Cost Of Revenue | 1.6B | 1.9B | 463.9M | 755.2M |
BeiGene fundamental ratios Correlations
Click cells to compare fundamentals
BeiGene Account Relationship Matchups
High Positive Relationship
High Negative Relationship
BeiGene fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.6B | 5.6B | 8.6B | 6.4B | 5.8B | 3.2B | |
Short Long Term Debt Total | 277.3M | 562.0M | 694.6M | 891.1M | 930.2M | 976.7M | |
Other Current Liab | 152.7M | 127.8M | 480.0M | 114.3M | 784.4M | 823.6M | |
Total Current Liabilities | 286.0M | 1.1B | 1.6B | 1.0B | 1.8B | 1.9B | |
Total Stockholder Equity | 978.4M | 3.9B | 6.2B | 4.4B | 3.5B | 2.2B | |
Other Liab | 57.1M | 443.3M | 562.5M | 283.7M | 326.3M | 342.6M | |
Net Tangible Assets | 956.3M | 3.9B | 6.2B | 4.3B | 5.0B | 5.2B | |
Property Plant And Equipment Net | 313.1M | 446.3M | 686.7M | 845.9M | 1.4B | 1.5B | |
Net Debt | (340.7M) | (820.0M) | (3.7B) | (3.0B) | (2.3B) | (2.1B) | |
Retained Earnings | (2.0B) | (3.6B) | (5.0B) | (7.1B) | (8.0B) | (7.6B) | |
Accounts Payable | 122.5M | 232.0M | 262.4M | 294.8M | 315.1M | 330.9M | |
Cash | 618.0M | 1.4B | 4.4B | 3.9B | 3.2B | 3.3B | |
Non Current Assets Total | 439.6M | 640.1M | 1.0B | 845.9M | 1.6B | 1.7B | |
Non Currrent Assets Other | 2.5M | 24.6M | 30.7M | (186.5M) | (18.7M) | (17.8M) | |
Other Assets | 108.7M | 186.8M | 8.6B | 819.9M | 2.0 | 1.9 | |
Long Term Debt | 240.7M | 183.6M | 202.1M | 209.1M | 197.6M | 143.1M | |
Cash And Short Term Investments | 985.5M | 4.7B | 6.6B | 4.5B | 3.2B | 2.3B | |
Common Stock Total Equity | 77K | 79K | 118K | 133K | 153.0K | 160.6K | |
Common Stock Shares Outstanding | 60.1M | 83.5M | 92.8M | 103.1M | 104.4M | 72.1M | |
Short Term Investments | 364.7M | 3.3B | 2.2B | 665.3M | 2.6M | 2.5M | |
Liabilities And Stockholders Equity | 1.6B | 5.6B | 8.6B | 6.4B | 5.8B | 3.2B | |
Non Current Liabilities Total | 347.9M | 656.3M | 803.4M | 977.9M | 423.6M | 372.9M | |
Other Current Assets | 85.8M | 133.0M | 246.2M | 190.9M | 205.5M | 215.8M | |
Other Stockholder Equity | 2.9B | 7.4B | 11.2B | 11.5B | 11.6B | 12.2B | |
Total Liab | 633.9M | 1.7B | 2.4B | 2.0B | 2.2B | 2.3B | |
Property Plant And Equipment Gross | 324.9M | 399.5M | 811.0M | 1.1B | 1.6B | 1.7B | |
Total Current Assets | 1.2B | 5.0B | 7.6B | 4.7B | 4.2B | 2.6B | |
Accumulated Other Comprehensive Income | (8.0M) | 6.9M | 18.0M | (77.4M) | (99.4M) | (94.5M) | |
Short Term Debt | 10.8M | 348.9M | 449.5M | 353.0M | 710.3M | 745.8M | |
Common Stock | 79K | 118K | 133K | 135K | 155.3K | 83.2K | |
Property Plant Equipment | 324.9M | 357.7M | 587.6M | 955.9M | 1.1B | 1.2B | |
Deferred Long Term Liab | 11.1M | 10.5M | 10.8M | 14.2M | 16.3M | 10.1M | |
Long Term Debt Total | 189.7M | 240.7M | 183.6M | 202.1M | 232.4M | 156.4M | |
Capital Surpluse | 2.7B | 2.9B | 7.4B | 11.2B | 12.9B | 13.5B | |
Net Receivables | 72.8M | 79.7M | 500.2M | 173.2M | 395.9M | 415.7M | |
Retained Earnings Total Equity | (1.0B) | (2.0B) | (3.6B) | (5.0B) | (4.5B) | (4.2B) | |
Inventory | 28.6M | 89.3M | 242.6M | 282.3M | 416.1M | 436.9M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.MSFT | Microsoft | |
GM | General Motors | |
CRM | Salesforce |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Complementary Tools for BeiGene Stock analysis
When running BeiGene's price analysis, check to measure BeiGene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BeiGene is operating at the current time. Most of BeiGene's value examination focuses on studying past and present price action to predict the probability of BeiGene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BeiGene's price. Additionally, you may evaluate how the addition of BeiGene to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
Is BeiGene's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BeiGene. If investors know BeiGene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BeiGene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.54) | Revenue Per Share 26.458 | Quarterly Revenue Growth 0.679 | Return On Assets (0.12) | Return On Equity (0.21) |
The market value of BeiGene is measured differently than its book value, which is the value of BeiGene that is recorded on the company's balance sheet. Investors also form their own opinion of BeiGene's value that differs from its market value or its book value, called intrinsic value, which is BeiGene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BeiGene's market value can be influenced by many factors that don't directly affect BeiGene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BeiGene's value and its price as these two are different measures arrived at by different means. Investors typically determine if BeiGene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BeiGene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.